About Index Trending news
Analyze
Pricing
Atopix Therapeutics

Atopix Therapeutics

Work at Atopix Therapeutics? Add yourself to this profile

Atopix Therapeutics

Edit Profile
More info

Elsewhere

Companies in the same industry

Esperion Therapeutics Esperion Therapeutics Mycodev Group Mycodev Group AFFiRiS AG AFFiRiS AG XOR Labs Toronto XOR Labs Toronto Prexton Therapeutics SA Prexton Therapeutics SA Pharmly Pharmly MyDentistChoice.com MyDentistChoice.com LeafLine Labs LeafLine Labs Promentis Pharmaceuticals Promentis Pharmaceuticals Perlecan Pharma Perlecan Pharma

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 1
Add info
Acquired by
21 Nov 2016
Chiesi Pharmaceuticals
€75,000,000
1
Latest funding
Debt financing
£3,250,000
Silicon Valley Bank
Locations
HQ
United Kingdom
Headquarters
€75,000,000
FinSMEs

Chiesi Farmaceutici Buys Atopix Therapeutics, for €75M

Health Strategy
Atopix Therapeutics
Atopix Therapeutics
Chiesi Pharmaceuticals
Chiesi Pharmaceuticals
£3,250,000 Debt financing
Added by
via FinSMEs

FinSMEs | Atopix Therapeutics Receives £3.25M Term Loan from SVB

Atopix Therapeutics
Atopix Therapeutics